Valsalva-Like Retinopathy Secondary to Pancytopenia following Induction of Etoposide and Ifosfamide.

Case Rep Ophthalmol Med

Department of Ophthalmology, Henry Ford Hospital, 2799 W. Grand Boulevard, Detroit, MI 48202, USA.

Published: February 2015

Etoposide and ifosfamide are chemotherapeutic agents used frequently in the treatment of sarcomas and hematologic malignancies. Ocular side effects are rarely reported. We describe a case of a patient on etoposide and ifosfamide who presented with unilateral vision loss, anemia, and thrombocytopenia. The patient was found to have a large subinternal limiting membrane hemorrhage in the right eye that is thought to be related to his anemia and thrombocytopenia. The hemorrhage resolved spontaneously after 10 days. This case illustrates how bone marrow suppression by chemotherapeutic agents may indirectly contribute to retinal hemorrhages resulting in at least transient vision loss.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324978PMC
http://dx.doi.org/10.1155/2015/985303DOI Listing

Publication Analysis

Top Keywords

etoposide ifosfamide
12
chemotherapeutic agents
8
vision loss
8
anemia thrombocytopenia
8
valsalva-like retinopathy
4
retinopathy secondary
4
secondary pancytopenia
4
pancytopenia induction
4
induction etoposide
4
ifosfamide etoposide
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!